A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Clinical trial NCT05817240 · COMPLETED

Trial details

NCT number: NCT05817240
Sponsor: Endeavor Biomedicines, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-05-03
Primary completion: 2023-06-11
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.